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The treetment of lobar pneumonia. has constit-
uted a harassing problerl to the Medical profession 
since the beGinning of 11'ledicine. As Osler' (39) said, 
tt Ever since the d8ys of antiquity, pneumonie has 
been observed and studied; while one method of treat-
ment after another has been vaunted with enthusiasm, 
only to be abandoned in despair; the disease mean-
while pursuing the even tenor of its way with scent 
regard for the treatment directed against it." That 
this statement, made thirty 'years ego, is still 
applica.ble today, is shown by the present mortality 
rate in this country. While the mOl"telity rate 
varies from year to yeer in the lerger hospitals, 
it remsins relatively fixed between 30 and 50 per-
cent. Even in priva.te practice, where the petient 
is given a more individualized type of treatment, 
the mortality is said to be no less than 25 percent. 
(11) • 
This paper is being written in e.n effol"'t to 
establish, in an unbiased manner, the value of one 
of the latest methods to be advanced for the treat-
ment of lobar pneumonia, na.nely; the therapeutic use 
of artificial pneumothorax. 
1 
\Yhile the advocates of this treatment do not 
clsim that it is e posi ti ve cm:~e for pneumonia, they 
do cleim some advantages to be ge,ined by its eppli-
c8tion, which in themselves ere impol"te.nt enough to 
merit its being given e ff.dr trial. 
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History of Pneumonia 
'rhe cheracteristic clinical picture so often 
seen in lobar pneu.monia has been recognized since 
the earliest times by the members of the medical pro-
fession. Hippocrates discussed pne'lJ.monie at quite 
some length in his writings, although B.t this time 
there was much confusion, end no d1fferentiBt1on be-
tween pneumonia, pleuritis and other acute thoracic 
diseases. Aretaeus, Celsus a.nd 'rhen1son, four cent-
uries after Hippocrates were the next writers to 
discllss pneumonia, contributing little however, to 
wh!'!t was already known. Diokles of ha.rystus, one of 
the oldest writers, is credited with having pointed 
out the difference in the pethology of pneumonif'l and 
pleuritis. Although mentioned end described in the 
writings of Galen, Caelius AureliBnus~ Aetins, Alex-
ander 'fhrellianus, Rhazes, Avicenna and others, no 
great advance was ma.de until the ere. which began ab-
out the time of Harvey, Sydenham end Melpighi, when 
physicians begen to think and investiga.te for them-
selves. 
The relation between the clinical menifestBt-
ions of pneumonia end consolidation of the lungs was 
first pointed out by Morgagni, while Baillie described 
t11e morbid process as If Hepatization tt Further 
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important studies were made by .0aennec, Cruveilhier 
and Roki tfmsky. The diagnosis of pneumonia. based on 
the physical signs is credited to Auenbrugger who 
discovered the possibilities of percussion, and to 
Laennec who fathered auscultation. Addison showed 
that the inflammatory eXUQate was extrevesiculer 
a.nd not interstitia.l, while to hokitansky belongs 
the credit of diffepentiating between the lobar a.nd 
lobular' types of pneumoni8. (57) 
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History of Pneumonie. Therapy 
Pneumonia. therepy hes s.n ancient background 
fully in keeping with thAt of the disesse itself. 
Hippocrates treated pneumonia by laxs.ti ves, expect-
orants, cups, or the sctue.l c 8 .utery a.nd with bsths 
on the fourth and seventh days s.nd oil inunctions 
on the fifth end sixth de.ys. ffhe princips.l food 
allowed was of fatty snd saline cherecter. Gelen, 
in 230 A.D., advocated venesection, a prectice 
which wes strenously opposed by Epistretus. Laennec 
sta.ted thet ft In every cese, the more feeble the pulse, 
the less the indication f'or blood-letting tl • (39) 
In 1830 Demees stated thet neerly all writers a.greed 
that the proper tres.tment of pneumonia. should con-
sist of; venesection, local and gener'al, purges, 
blisters , Alteratives, 8.ntimony end tonics. At this 
time, blisters were considered as being, next to 
venesection, the most efficscious remedy for pneu-
monia. They were not only applied to the chest, but 
to the legs, thighs or inside the arms. \7hen they 
failed to act as derivatives, they were supposed to 
s.ct beneficislly by exiting temporarily, the powers 
of the system, thereby making further bleedings pos-
sible. 
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Alkelies wel'e used by the a.ncients to render 
the blood less plastic. Subcerbons.te of soda, pota.-
ssium or emmonium soap, 81so the sulf'etes of sode. end 
pots.ssiurn were used. The fe.ct that hepatized portions 
of lung pIeced in 8.n alkaline solution softened, lent 
strength to this opinion. As recently as 1919 alka-
lies were advocated by different men in this country. 
(50) (56). 
Purgatives and emetics were used freely with 
the view of lessening the congestion within the chest 
or on the theory that the inflammation might be 
complicated with a bilious disorder. 
Calomel a.nd opium seps.rately or com-bined, were 
extensively used in England. Gs.lomel wS.s often 
given to the point of salivation. (rarter emetic in 
large doses was used in Ite.ly and also by Laennec in 
J:;'ra.nce. (rhe drug wa.s given in sufficient doses to 
CHuse the patient to vomit two or three times 8nd to 
produce five to six stools a. dny •. (rhe ItHlians gave 
a.s high as sever81drachns in twentYf-four hours and 
controled the vomiting and diarrhea by syrup of 
poppies. (14). 
Vihat was undoubtedly one of the most salutory 
events, so far as tr'eatment is concerned, was brought 
6 
; , 
out by the \fienne school of Therapeutic Nihilism, 
lead by Skoda. As a result of its doctrines the fect 
was thoroughly demonstreted thet pneumonia is 9. self 
limited disease with a netural tendency towerd re-
covery, and that nature cen do more for the patient 
than the routine application of Flny one method of 
treatment indiscriminately applied. 
Up to 1910 there were a host of vaunted spe-
cifics. ,l:<'lint (22) once claimed that qUinine in 20 
to 40 grein doses would Rbort pneumonia. Schwartz 
(47) cleimed that iodine wes e specific, and at dj,f-
ferent times, veratrum viride, ammonium cerbonete, 
ergot, selicylates, sodium benzoate, creosote carb-
onate and othe:;~ drugs ha,ve c12imed this distinction. 
About 1910 vaccines and serums ceme into pro-
minence. Al thou~h serum treatment in lobar pneumonia. 
h!=ld been attempted as eerly ss 1897 by Weshbourne, 
(55) his serum treatment was a failure bec2use he 
was unaware of the existence of the different strains 
of pneumococci. 'roday the serUM treetraent is used 
in pneumonia caused by the Type I and Type II pneumo-
cocci, and is said to reduce the mortality ten to 
fii'teen percent. (52) Vaccines, while they are of 
some value in the tl"estment of bronchopneumonia, (31) 
are of little or no vahle in the treetment of lober 
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pneumonia. Park (£12) in referring to a series of 
cases of lober pneumonia tx'eated with mixed stock 
vaccine says, II In fact, if we hed not known that 
the vaccine was being given to one-helf of them we 
would never h~:tve suspected frol:1 the course of the 
dj.sease thet e.ny special form of treetment was being 
gi ven!!. 
ux;rgen therapy was first used by Chambers, (12) 
v"I'110 re ported on it in 1890. 11'his method of treatment 
is still widely used at present 8.S a method of symp-
tomatic treatment. McCurdy, (35) summing up the pne-
sent day ste.tus of oxygen therapy, ste.tes that it is 
nei ther a pneumonia. cure, nor a re susci tat or of mor-
ibund pa.tients, yet properly used, should always be 
a value.ble aid to recovery and yield gratifying relief 
of s Yr.1pt OtlS • 
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History of Artificiel Pneumothorex 
In 1821 James Garson, 8 Scotch physician and 
physiologist, working in Liverpool, recognized the 
therapeutic possibilities of artificial pneumothorax 
and proved its practicability by animal experiment-
ation. In 1822 he published B.n article advoceting 
its use in the treatment of pulnonary tu.berculosis. 
~ehere is however, no record of his hBving tried it 
out on 8 humBn sub,iect. Artificial pneu.rnothorax 
was next heard of in l8~32 when ;VlcHuer of Bangor 
lvlaine, suggested its use for the immobilizstion of' 
a diseased lung. Again no one actually tried to 
carry out the treatment and Bga.in it was forgotten; 
this time for fifty years, until in 1882 when For-
lanini of Italy suggested its n.se in the treatment 
of tuberculosis. (9) 
Although there is reference in the literature 
to the introduction of air into the chest for the 
treatment of disease by the Greek physicians in the 
4th century B.G., the modern practice of artificial 
pneumothorax detes, ei thaI' bBck to 1888, wb.en Forlan-
ini introduced air into the pleural cavity of a pat-
ient suffering from a pleural effusion, (40) or ba ck, 
as some authorities oj.airel "L 0 1884 when Pot8in B. Prench 
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physician replaced the effusion in a case of hyd-
ropneumothorax with sterile eire (9) (3) Be that 8S 
it ma.y however, it was first used for the collapse 
of f1 diseased lung in 9. person suffering frm:! tub-
erculosis by Porlanini, in 1892. 
Apparently not knowing of the 1,'Jork of }'or-
lanini and from independent thinking and observations, 
Hurphy, of Chicago, reported in 1898, five ceses of 
tl.1bex"cl.11osis that he had treated with artificis.l 
pneumothorax. (38) (54) Tice began to use artj.ficial 
pneumotho:t'8.x about the same time as Murphy. Lempke, 
one of hIurphy's pupils, carried on the work with ert-
iricial pneumothorax when Murphy dropped it. Since 
that time artificial pneumothore.x has become B. stan-
dard method of treat·ment in tuberculosis. 
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Pneumothor8x in Pneumonia 
(8 review of the literature) 
'llherepeutic pneumothorax PS 8. f1ethod of treat-
ment in lobar pneumonia hes been used by Europe2n 
pnysici9ns since 1921 when l"riedemann (23) reported 
on its use in seven patients. He is given credit 
for being the originator of this form of pneumonia 
therapy. He found that when 8rtificial pneumothorax 
was instituted on the affected side, sever'e pPin sub-
sided and respi1"stion became quiet, with evident im-
prover1ent in the general condition. In 1921 David 
(19) also reported six cases with favorable resnlts. 
':Cwo of his patients recoveped by lysis, the other 
four recovering by crists, 8.11 without comp1ic8tions • 
.t.n 1922 'Wynn, (59) in this country, while not actua.lly 
using pneumothorax, says, It In 8 few CBses with very 
severe pBin (pleurisy) I have separated the pleural 
surfe.ces by trie introduction of 8 small Quantity of 
oxygen. '£1his is not difficult to those accustomed 
to the 8rti1.'iciel pneumothor8x tre8tment, and I was 
favorably impressed with the immediate relief given. ff 
Ibreham and Duken (29) used it in three inf8nts with 
pneumonia with recovery; and lJuken (20) leter succes-
sfully treated five othe r children with pneumonia. by 
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this method. In these patients, treatment WBS given 
late in the disease ( twelfth to the thirty-fifth 
day) and must be pegerded as being given for a com-
plicBtion of lober pnenmoniB. pather then for the 
~1cute pneumonia itself. 
Leiberman Bnd Leopold (33) in 1921::1, reported 
a series of cases of artificially induced pneumo~i8 
in dogs, which they treated with ertificiBl pneumo-
thoPBx. In B. group of 3b anima.ls, one-helf were used 
,8.S controls and one-half were given artificiBl pneu-
mothorax. Of the 18 untreated control dogs, 13 died 
and 5 recovered; of the 11::1 treBted with artificial 
pneumothorax on the second day, 15 recovered and 3 
died. 'rhese worke:r~s report, II Our expe ~mentBl study 
indicetes that the introduction of eir in the pleural 
cavi ty in the proper £l.ffiount on the affected side Dro-
.\" I 
I 
duces, temporarily at least, e picture compRrable to 
the crisis in lobar pneumonia and achieves B.n arti,. 
ficial limi tB.tion of an otherwise seLf'-limi ted dis-;-
ease. In addition to this, in the experimental 
animal, this treatment a.ppears to heve a favorl?ble 
effect on the bloodstream invBsion. II 
In 1931 'l'aylor (53) used artificial pneumo-
thorax in the treatment of' pleurisy in pneumoni8 i* 
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three cases with immediate relief of peine In 1932 
Coghlan (13) I the first to use it in this country, 
i 
used it in six cases of lobAr pneur'1onie with complete 
recovery in five cases. In the one fatal case, en 
attempt wes mede to produce en immediate end complete 
crisis because of too desprete condition of the pe.t-
ient. 750 cc. of sir was injected at one time; a 
very violent crisis set in, the patient perspired 
freely end the cyenosis became markedly diminished. 
A few hours later the pulse began to rise and signs 
of fail'\J.re of the right ventricle appeared, the pet-
ient dying the next day. He seys, " fllhe fet81ity in 
this aase can be a.ttributed to an error in judgement 
in a difficult situation end leck of knowledge of 
the technique, owing to inexperience rather than to 
a detect in the method of treatment itself, for it 
was obvious that the pneumonic process wases well 
controled by the ertif'icial pneumothorax in this 
instance es in the other cs ses. II 
Cogh18n IS workhes stimuleted others to use 
this form of thel"'spy and in the. past hanau (26) and 
Gueae.rre.me (25) have comrnented ravore.bly on its use 
in lober pneumonia and the latter has published one 
cese. Li (32) reported six ce.ses i'rom China with 
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one fatality in a CBse that also had an effusion in 
the right pleural cavity. Anderson (1) reported 
three CBses with complete recovery. Perlroth Bnd 
~opercer (43) treated seven patients with one death. 
'fhe fBta.lity occured in 8 chronic alcoholic with 
confluent bronchopneumonia and ,iaundice. Blake et 
al (7) report favora.bly on twenty-two CBses treated 
by artificial pneumothorax with three deaths from 
septicemia. In tl~ir series, treatment was instit-
uted on Dr before the fifth day. I1Ioorman (36) in 
1934 reported two CBses which he had treated in 1930; 
both of these patients were seen lete in the disease 
and in !:t very toxic state. Both died, but rather 
from the advanced sta.te of tne disease than from the 
pneumothorax treatment. Late!r' in the year he report-
ed (37) eight more CHses with one death. This petient 
died of a massive cellulitis in the region of the per-
otid glend which failed to localize. He states that 
the interval between fillings should not exceed twelve 
to twenty-four hours. Behrend snd' Cowper (4) treat-
ed eleven cases with two fatelities, one of which 
wa.s rnoribumd when first seen, and all who saw him 
thought that his life had been prolonged; the sec-
ond died of pneumococcic :aeningi tis on the twenty-
first day of the disease. In neither of these two 
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cases can the cause of death be even remotely 
attributed to the pneumothorax treatment. Isaacs et 
13.1 (30) reported seven ca.ses with four :ratali ties, 
and of this method of treatment say, If The treatments 
were not associated with eny nnt oward effects, and 
no deaths or complications could be attributed to its 
usage, thus proving that pneumothorsx treetment in 
lobAr pneumonia, is not 'associated with symptoms of 
shock. II Crowell (18) reported three cases, all of 
which recovered without complications. Riggins (44) 
reports six ca ses with no deaths, the trertnent hav-
ing been started on the second to the fourth deys. 
Hines and Bennett (27) reported twelve cases treat-
ed with pneumothorax with four deaths. Holmes and 
Handolph (28) treated eighteen cases by this method 
with two deaths. They believe thet the total mort-
slity in pneumonia is reduced by the use of pneup1o-
thorax treatment, a.nd the chance of latE3 complications 
such as abscess, bronchiectasis or unresolved pneu-
monia is probe.bly reduced. Stoll et al (51) treated 
twenty-fi ve unpicked cases of pneumonia. with pneumo-
thorax and had seven fatalities. Fentress (21) treat-
ed eleven cases by this riethod and had two deeths. 
In his se ~('ies, tree t, ~-1:3nt wes begun from the second 
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to the eleventh da.y of the disee.se. He says, It The 
da.y of treatment makes no difference, yet, as in 
serum the:l"'apy, tree.tment sl:lOuld be begun as soon 8S 
th d " ". d It .e 1agnos1s 1S ma e. Robbins (45) reported five 
cHses in which treatment wa.s begun on the fourth to 
the eighth day, with definite improvement in each 
ps.tient, none of whom died. Shipman 8nd Cox (49) 
had twenty-two cases with four deaths. Two of the 
patients were moribund when treatment was begun. 
'llhese men sa.1, rl We believe tha.t the toxemia ma.y be 
diminished in oertain insta.nces and the subsequent 
course changed for the better. It is our impression, 
however, that once air is introduoed into the pleural 
cavi ty, it should be given for at least two weeks to 
allow the inflammatory reaction in the pleura to sub-
side. Otherwise, sterile effusions, which prolong 
the petients stay in the hospitel, ma.y be expected 
to develope. tI 
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Pathogenesis of Pneumonift 
The exiting cause of lobar pneumonia is the 
pneumococcus but, predisposing CBuses also play an 
important part. When virulent pneumococci get into 
the throB.t the germs do not pS.ss down the bronchial 
tree to the lungs. In man accessory factors are 
necessary to lower the resistance of the patient·. 
'the best recognized of' these ere; profound fatigue, 
chill, injury to the chest, severe fractures t the 
inhalation of an anesthetic, and some other infect-
ion ( influenza, the infectious fevers, etc.). 
'l'he route by Which the pneumococci reach the 
lung has long been a metter of dispute. '1lhe oppos-
ing views s.re; (I) That the infection is bl"oncho-
genic, passing down the bronchi into the lung; (II) 
ths.t it is hemat ogenous, passing from the throat into 
the bloodstream 8.nd reaching the lung by that route. 
1'he work of Blake and Cecil (6) has proven quite 
conclusively that the former theory is correct. 
'1'he pneumococci penetrate the walls of the 
l~lrger bronchi, enter the lymphatics of the intel"-
sti tial framew ork of the lung, a.nd by this route reach 
the walls of the alveoli. '1'hey ps.ss through these 
walls and entel" the al vo oli in la.rge numbers. 
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Meanwhile, invHsion of the blood stream has occured, 
probably by way of the lymphBtics, the organisms 
being found in blood culture in from six to twenty-
four hours after injection. It is this early blood 
infection that gave rise to the idea of the hemato-
genous mode of pa.thogenesis. 'l'he funde,menta.l feature 
of the process is the interstitial invBsion of the 
lung, and it is from the interstitial tissue, not from 
the bronchioles, that the Blveoli 8.re reBclled. The 
eHrliest lesion is an interstitial inflamma.tion aff-
ecting the peri vasculflr e.nd peribronchia.l connective 
tissue, but this inflammation is not severe Hnd the:::re 
is no destruction or tissue necI'osis. 
According to Boyd, (8) the essential patho-
logical feature of pneulnoniH is an out-pouring of 
B.n infla.mmatory exudate into the alveoli in response 
to the ir'ritation produced by the pneumococci. The 
alveoli are filled by this exudate, the air is dis-
plHced, end the lung or pe.rt of it is converted into 
a solid and airless ol"'gan. 'llllis process is known es 
consolidation or hepatization because the lung be-
comes like li vel'" in consistence. 'l'1'1e process is e 
progressive one commencing et the hilus Hnd sweeping 
out to the periphery, L::.vol ving one or more lobes 
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end sometimes both lungs. It follows thet one pert 
of the lung mey be at one stage while enother pert 
is Bt another. 
'rhe gross appeerence of lober pneu.monia is 
very characteristic. By the end of the second day 
the stage of red hepRitization has been reached B_nd 
the affected part is consolidated, swollen end red-
dish brown in color. Only one pert of a lobe msy 
be consolidated, and the line of separation between 
the two pa-rts is remarkably sherp. When the stege 
of grey heptltize.tion is reached, usua_lly by the fifth 
day, the consolidated part is grey or brownish-grey 
in color, and it is now distinctly. moist owing to 
softening of the exudate. '11he bronchial lymph nodes 
are enlarged and congested. In the stege of resolu-
tion, the lung has become soft and translucent, end 
may be almost jelly-like in consistence. 
£o'or the production of the scute syndrome known 
as lobar pneumonia, another factor besides the pres-
ence of the pneumococcus is necessary; this is the 
occlusion of 8. bronchus by the pneumococcic bronchiel 
exuuete. (17) 1'his ma rks the onset of a clinics 1 
syndrome in which 8:('e 1mited the clinicel features 
of 8.n Bcuie obst~lctive atelectasis and en acute 
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obstructive etelectpsis 2nd pn pcnte pneumococcic 
cellulitis. rrhe fectors which ["lake this occlusion 
possible are, the vi scld and tenacious nature of 
the pneumococcic spu.te"'1, the dinlnished force of 
expectoration in 8 toxic individual, perhaps) the 
edena of the bronchipl mucosa, end possible dsmege 
to the ciliated epithelium. Goryllos 2nd Birnbaum 
(15) (16) (17) heve done e greet deal of work, prin-
cipally anima.1 experimentation, on massive atelect-
asis and lobar pneumonia. In massive ate1ectesis, 
they find, the bronchUS i.s often occluded by 8 rel-
stively poox'ly infective secretion, and the toxic 
symptoms are absent; whereas in lobar pnem:lOnia, the 
viscid occluding secretion is infected with pneumo-
cocci from the stl?rt, the number end vir·l1.lence of 
the organisms determining the degree of toxicity of 
the disease. The obstruction having once set in, 
ebsorptibn.of tre 81veolsr pir proceeds; simultsneonsly 
the infection is sp:('eading to the periphex'Y of tr.8 
lobe by septal 2nd inter8lveolf'r lymphatics. 
Absorption of endotoxins in rmeurrwni8 expl-
ains the toxic eler1ent "\:11icr" is usn~·lly absent in 
simple atelectasis. ~he topography and size of the 
bronchus occluded ,:",tle duration of the occlu.sion, 
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the virulence of the infecting organisms 2nd the 
I'2pidi ty of the developement of the pneumococcic 
cellulitis will determine the fentures of lober 
pnelJ.monia. Occlusion of a lerge bl"'onchus with pneu-
f:lOCOCCUS of a low virulence will produce n syndrome 
closer to a massive atelectasis than to lobar pneum-
onia, while occlusion of a bronchus with highly vir-
ulent pneunococcus will cause 8. more typical and toxic 
lobar pneumonia. 
In its earliest period, 10bBr pneumonia 
presents 1"2,di ographic and auscul tat ory s y:rapt oms of 
a lobar atelectasis, namely; a vvedge sh8ped shadow, 
mo:c'e or less mer1:;:ed, absence of respiratory breeth-
ing, with a J'B.ther tyrnpe.nitic dulness over the effec-
ted area, and often a homolateral displacement of the 
mediastinum and elevation of the diephragm on the 
e,f'fected side. Simultaneously, the cellulitis spreads 
from the hiler portion of the lobe to the periphery 
accompanied by the phenomena of l~meU!:lococcic inflam-
mation, namely; congestion, interstitial and lymph-
atic infiltration, vascular engorgement and product-
i on of the cll aracteristic fibrinous exudate. 
'I'he roentgl'am end physical signs of lobar 
a.telectasis, which 8,1'e.,1.((; to the obstruction of a 
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central bronchus, appear to proceed from the peri-
phery to the center of the lobe, because the absor-
ption of the alveolar air is more merked in the per-
ipheroy of the lobe, where the alveo±Li Lare more num-
erous. frhe symptoms of the pneumococcic cellulitis, 
on the contrs.ry, apread from the central infectious 
Itplug lt to the periphery, following the lymphatic and 
interstitial tissue, so that after the initial and 
transitory period of simple s.telectasis there is a 
period of pneumococcic invElsion. Engorgement, red 
hepatizEltion, grey hepl;litzation a.nd resolution, 
follow one another from the center to the periphery. 
When the hilar portion of the lobe shows engorgement 
and even red hepatizati on, in the pe riphery, we still 
find-alveoli, more or less atelectatic, but free from 
exudate. When grey hepatization starts in the hiler 
portion of the lobe, the more peripheral pa.rts show 
red hepatization; when, after the resolution, the 
proximal portion of the lobe has drained and become 
aerated, the peripheral part still contains fibrin-
ous exudate, more or less liquified by the ~lCtion of 
the proteolytic enzymes produced by the white blood 
cells. 'Thus the shadow persists even after the crisis 
in pneumonia and gradu8.11y disappears 1'rom the center 
22 
to the periphery. 
The simultaneous developement of atelectasis 
. ano. pneumococcic ee lluli tis expla.ins the less me.rked 
displecement of the medie.stinum in pneumonis. ths.n in 
massive atelectasis. Besides, the lesion is often 
limited to one lobe, and the inflammatory swelling 
of the interstitial tissue and alveoler exude.tion 
prevent shrinke.ge of the lung to the extent found in 
simple atelectasis. 
The crisis or lysis is due to the disintigrat-
ion of the fibrinous exudate which characterizes grey 
hepatization, and to the sudden liberstion of B large 
b:eonchus, thus allowing sudden draina.ge of the afi'ect-
ed lobe. If the liberation is complete and rapid, 
a crisis follows; if it is gradual, the healing 
occurs by lysis. (17) 
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Rationa.le 
Coghlan, (13) in his original paper claimed 
the following adv8.nta.ges for the tre etr;1ent of loba.r 
pneumonia with artificial pneumothorax; (I) that it 
separated the inflamed pleura.l surf~lces, relieving 
pain and allowing easy respiration, (II) that it put 
t re inflamed lung B.t rest, and (III) limited the 
flow of blood through the pneumonic lung, thereby 
diminishing anoxemia and interfering with the pass-
a.ge of toxins into the general circulation. Bullowa 
and Mayer (10) state that the mode of action of art-
ificial pneumothorax is It a naturel surgical method 
of placing the lung at rest, and is comparable to 
splinting an infected ha.nd to a.void blood invasion 
and sprea.d of the infection. tt 
Moorma.n (37) gives five indications for pneu-
mothora.x in the trea.tment of lobar pneumoni~l. These 
are, (I) e.telecta.sis, (II) pleurisy, (III) to separ-
ate inflamed surfaces, (IV) to provide local rest 
and (V) eaI'ly treatment. 
Atelectasis constitutes a very definite ind-
ica.tion for a.rtificial pneumothorax in pneumonia .• 
This condition, depending upon the degree and extent, 
may give rise to symptoms and physica.l signs ranging 
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fr~om slight intra.thoracic distre ss with possibly 
slight deviation of mediastinal structures toward the 
affected lung, to pronounced pain and distress (so-
called respiratory ca.tastrophe ) with marked displace-
ment of heart, great vessels and tra.chea toward the 
a.ffected side. 
Since the above phenomena are due to intra-
thoracic negative pressure, the introduction of a 
f-ew hundred cubic centimeters of a.i1" into the pleura.l 
space will promptly restOl~e the norma.l rela.tionship 
of the media.stinal structures a.nd re lieve the pain 
and distress. Griffith, (24) Wu, (58) and Robertson 
et al, (46) ha.ve shown by their studies that atelec-
tasis is not uncommon in pneUll1onia .• 
Pleurisy pain which is so cownon and often so 
persistant in pneumonia may be a.ccepted a.s a. direct 
indication for pneumothorax. 'rhe relief of pain B.nd 
the resulting comfort with peaceful sleep, obviating 
the necessity of large doses of opium a.nd other sed-
atives, must favorably influence prognosis. There 
is a marked reduction in the frequency and severity 
of cough and the associB.ted sta.bbing pa.in is reduced. 
It may be possible to limit the spread of 
pleural inflamma.tion and decrea.se the inciCience of 
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empyemEt by interposing a cushion of air between the 
two pleural surfaces and thus intercepting the con-
stant friction and agitation which must result in· 
aggravation a.nd dissemination of infection. 
When we consider the na.ture of the infection, 
the structure of the lungs, and the influence of gre-
vi ty, plus the possible periphera.l suction due to 
atelectasis , it seems quite rea.soneble to believe 
ths.t by mea.ns of collapse therapy, secretions and 
inflamma.toJ'Y exudate may be expressed and their pro-
gress toward the periphery retarded!, The absorption 
of toxins will be lessened due to the diminished 
flow of blood end lyrnph. (48) (2) (36). 
Artificial pneumothorax not only brings rest 
to the inflamed lung and pleura, but through relief 
of ps.in and added comfort it favors general rest. 
Loc·al rest is important in the treatment of inflemm-
etion in 8.+1Y orga.n; it is doubly important in the 
inflamed lung wher'e, in spite of the ultimate inhib-
i tory action on the pa.rt of nature, function goes 
on until curtailed by a.rtificial mea.ns" 
It is generally agreed that artificial pneu-
mothorax is particularly indicated early in the course 
of pneumonis." It seems r'e880Ds.ble to expect better 
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results if collapse can be induced before the lung 
tissue is conpletely consolida.ted and the infls.mmat-
ory process is widely distributed; before the patients 
vits.l for.ces become depleted by toxemis. and before 
the developement of cardio-respiratory distress due 
to atelectasis and pleurisy. Clinical experience, 
plus roentgen ray evidence indicates that the more 
complete the consolids.tion, the more incomplete the 
collapse from pneumothorax. Lieberms.n and Leopold 
(34) state ths.t artificis.l pneumothors.x shouild be 
used early to be effective; in fact, they find evi-
dence to justify its being contraindicated after the 
third dB.y of the disease. 
However, one must not lose sight of the fact 
that var'ious complications, disadvantf:'ges and pos-
sible dangers have been mentioned in the literature. 
Coghlan, (13) in his pS.per mentions pyopneumothorax 
and cardiac collapse as possible dangers in the use 
of this method of treatment. .?yopneumothorax is 
easily prevented by the use of aseptic technique, as 
was pointed out by Coghlan himself. Cardiac collapse 
can occur as a result of a crisis which is too severe. 
This can be controled safely by lessening the amount 
of air administered at the first injection. 
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Bullowe and Meyer, (10) in their paper on the 
hazards of this method of treatment, list eight comp-
lications and disadventages, which are; lI(a) Late in-
vasion of the bloodstream in spite of collapse, (b) 
Invesion of another lobe on the collapsed side, (c) 
Invasion of the contralateral side, (d) Empyema., (e) 
Induced rupture of the lung, (f) b;xtre111e mediastinal 
shift, with death, (g) Ha.rmful deley in application 
of serum therapy in suitable cases, (h) .\:<IBtigue of 
patients by frequent manipulations and roentgen ex-
aminations. II 
Date invasion of the bloodstream in spite of 
collapse treatment does not occur when collapse is 
obtained on or before the third day of the disease. 
According to .uieberm9.n and Leopold., (3~'S{ (34) ten-
dency toward bloodstream invasion is lessened with 
pneumothorax, although it probably has no effect 
upon a preexisting bloodstream infection. 
Spread of infection, either homolateral or 
contralateral, is probably not influenced by this 
method of treatment, when the treatment is insti t-
uted before the third dey. However, there is some 
evidence to prove that the chances of spreeding the 
infection a.re increased by ertificia.l pneumothor'ax 
after the third day. 
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According to [,roorman (37) the prevention of 
empyena is one of the indications fop the use of ert-
ificial pneuMothorax. In children however, this tr-
eatment is contraindicated becBuse it has been found 
that it seems to increase the occupance of empyema. 
Also, the tendency toward spontsneous pne'l}mothorax 
is greater in children than in pdults. 
Induced rupture of the lung is e more or less 
mythical complication or danger. Its possibility be-
ing practicBlly precluded by the proper use of the 
r:1anometer while the treBtment is being given. 
Extreme mediastins.l shift as a dangerous comp-
lication and a cause of deeth can be dismissed by 
reiterating the necessity for taking frequent manom-
eter reHdings during the injection of the air. Paying 
close attention to the patients subjective complaints 
a.t this time is another safety factor ~lDd as such is 
ppobably a.s importe.nt es the menometer readings, be-
cause pain end distress are the first signs of med-
iastinal shift. Injection of more than two or three 
hundred cubic centimeters of eir is not necessary for 
adequate collapse, and if exceeded carries with it 
the dangerbf mediastinal shift. 
'rhat harmful dels;, in the application of serum 
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therapy is entailed by the use .of artificial pneumo-
thorax is a nistaken claim because serum treatment 
need not be omitted or delayed when artificial pneumo-
thorax is used. In fact, it may be soon f'ounp. that 
a combination of' these two methoc.s of treatment is 
the best yet to be proposed. 
Fatigue of the patient by frequent me.nipule.-
tiona and roentgen examinations need nbt be a dis-
advan~age, as claimed, because of tL6 simplicity of 
the se ma .. nouvers, s.nd the infrequency with which they 
must be carried out~. 'l'he x-ray is only needed for 
confirming the diagnosis and locating the exact site 
of the consolidated area. 1'his can be accomplished 
by the portable equipeY'lent at the petient I s bedside 
and with no discomfort or exertion on the part of 
the pe.tient. 'l'he pneumothorax itself requires only 
about five minutes for induction and is done with-
out moving the patient from his bed. 
30 
It should be remembeI'ed that the induction of 
al"tificial pneumothorax, even in the hands of e. skill-
ed operator , is a hazardous procedure. Vie cermot 
escape the de.nger of suaden death from air embolism, 
or so-called pleupal shock. 'rraumatic 01' sponts.n-
eous pneumothorax with bronchial fistula may be ac-
companied by extl"eme shock, and empyema is e. dangerous 
complica.tion. i.Llhese sre the most hs.zardous complic-
ations and their incidence mat be greatly increa.sed 
by inexperience, lack of skill, and improper tecr .. nic. 
A working knowledge of the pneur,lOthora.x 8.ppa'ratus to 
be used is prerequisite. 
It is important to use at the first opere.tion 
a needle of proper size, guage 18, with a blunt point 
or a bevel approximating 45 degrees. 'llhe stilet 
should be well fitted. If these preca.ntions are dis-
regarded, grave damage to the visceral pleura may 
result. Such accidents may occur even though every 
safeguard is employed. 
In pneumonia it is not necessary to turn the 
patient on his side with a pillow unde:r> his thorax 
in order to bring the field of operation into bold 
relief and to v,iden the interspaces. Pneumonia. is 
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an acute inflammatOI'Y disease ana demt:mds gent le 
handling. With rare exceptions, the best position 
for the. operation is the position Bssumed by the pe-
tient when left to his own wishes. 'l'he field of 
operation should be preferably in the lower hBlf of 
the thorax, anYVihere above the diaphragm between the 
ma~nary line and the paravertebral line. If the pa-
tient is lying on his back, the needle may be intro-
duced in the anterior axillRry line, in the third to 
the fifth interspaces. If the patient is in the lat-
eral position, affected side down,· because or the. 
pleural pain, a change of position mey be necessary 
in order to select a desirable field for operation. 
'rhe patient's interests ere safeguarded by 
attempting, as far as possible, to keep the field of 
operation away from the location of gross aisease as 
determined by the signs of consolidation, ple1.J.ral 
friction, and roentgen r8.Y findings.. Ii' introduction 
of the needle should traumatize the visceral pleura, 
repair without infection and serious aamage will be 
more likely to occur if the point of attack is out-
side the field of acute inflammat01~~:{ reaction. 
'l'he field is prepared with elcohol sn6. iodine 
and at the chosen point the local anesthetic is 
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introduced. (novocaine, i of 1% or procaine hydro-
chloride 2%) With a small hypodermic syringe and a 
fine sha.rp needle, the skin wheal is Made and then 
the needle is directed perpendicula.rly toward the 
pleura, with progressive infiltration, until the pa-
rietal pleura is anesthetized. When the parietal 
pleura is penetrated, the p±~ton of the syringe vol-
untarily descends with each inspiration in response 
to the intrathoracic negeti ve pressure. However with 
increased resistance due to thickened pleura, there 
is no indication of negntive pressure manifest at this 
time. 
After anesthesia., the needle used to insert 
air is introduced. Since the point of the needle is 
rels.tively blufut, the skin ma.y be penetre.ted with a 
catsract knife or preferably B sharp pointed needle 
with caliber corresponding to that of the needle.that 
is to be used. 'Jihen the pneumothorax spa.ce is suff-
icient to obviate the danger of contact with the vi-
scers.l pleura, an ordinary needle may be employed for 
refills. il{lHnometer readings beer the SHne significant 
indications routinely Hccorded them in tuberculosis 
CHses and should be more highly respected because of 
the increased danger of deBling with an Bcute 
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infectious disease. ~ree oscillations should be se-
cured before the air is introduced. As air is admit-
ted, frequent manometeI' readings ere necessary to 
avoid the danger of unexpected positive pressures. 
Behrend and Cowper (4) advocate manometer reedings 
after every 50 cc. of air is admitted. It may be safe 
to close with neutral pressures, but, with few ex-
ceptions, positive pressures should be avoided. 
rl'here can be no inflexable rule with reference 
to the amount of air to be given, due to the aiffer-
ence in, the size of tile thoracic cages of the various 
patients, the elasticity of the pleura, and the sta.ge 
of developement of the consolidation process. Exper-
ience with pneumothorax in otl:ler conditions suggests 
the.t the closing pressure accompanying the initial 
filling should be negative, or at least not above 
neutral, and tile amount of air introduced should not 
exceed 300 cc., even though tl~ pressure remains 
negative. Behrend end Cowper' (4) however, feel that 
from 400 to 500 cc. of air will usually produce the 
desired effect without producing a mediastinal shift. 
;l'his would seem 9. safe rule to follow in pneumonia .• 
While there is some di1'fe rence in opinion, 8. review 
of the reported cases indicates that with few 
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exceptions, these bounds have not been exceeded. 
~he amount of air introduced has vpried from 80 to 
700 cc., and the number of fillings from one to three. 
'Ehe interv9.1 between fillings has vRried from twelve 
to thirty-six hours. The probe.ble increase in the 
rate of absorption in pneumonia, (13) (34) and the 
desirability of maintaining e feir degree of collapse, 
suggest that the interv8.1 between fillings should not 
exceed twelve to twenty-rour hours. (37) 
Worthy of considers.tion is the fpct th9t in 
the employment of ertifici8.1 pneumothorax the oper-
ator can promptly retrace his steps by the with-
dr8.wl of th(il) air from the pleura.l space. 
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Summary 
In 1892, Osler (41) said, " Pneumonia. is a_ 
self-limited disease, end runs_its course uninfluen-
ced in any way by medicine. It can neither be abor-
ted nor cut short by a.ny known means at our command. If 
Surgery now has a way to cut short the course of 
pneumonia a.nd to relieve its a.ttenda_nt suffering. 
At the present time, about 200 ca.ses of lobar 
pneumonia. which have been tree.ted with artificial 
pneumothorax have been reported in the li tera.ture. 
'1'he mortality for thid group of ce.ses has been pract-
ically the same as the genera.l hospital mortality from 
this disease under all other forms of treatment. Tt 
seems likely however, that this mOil1ts.li ty rate will 
decline as this form of treatment gets out of the ex-
pel"imeptal stage which it is in at present • Hereto-
for, it has not been 13_ standa_rdized or even thoroueP ly 
understood method of treatnent. Everyone using it 
had his own ideas about how and when to use it. As 
8_ result many mistakes in judgement end technique 
have undoubtedly been ma.de. There have been a 
sufficient number of cases published now, that there 
should no longer be an excuse for patients dying due 
to lack of clinical skill and judgement on the pert 
of the operator. One should keep in mind Coghlan's 
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(13) admonition that, It Lobar pneumonia is emphat-
ically not the disease on which to gain a knowledge 
of the technique of artificial pneumothorax. lI , which 
conts.ins as much truth today as the day he wrote it. 
It seems fs.irly well established tha.t the 
pneumothorax treatment dows not increase the amount 
or number of complications of pneumonia. In fact, 
when used properly,. it will without a doubt reduce 
the number of complications. 
The. only contraindications to its use seem to 
be in 81':1all children, and in s.ny one after the third 
day of the disease. VJhen used in children, it seems 
to increase the tendency to form sponte.neous pneumo-
thorax, a fect which is against its use. Unless 
used before the third ds.y, there seems to be El slightly 
higher incidence of spread of the involvement, either 
to another lobe on the same side, or to the other side. 
'I'he greatest obstacle to effective early 
treatment is the presemce of preeXisting filQrous ad-
hesions in almost 50% of adults of middle age. This 
barrier is almost insurmounte.ble in patients treated 
after the third day because the pleural reaction 
after this time adds new adhesions to the predicts.ble 
50?~ already present, thUG ':18king complete compression 
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and artificial crisis virtually impossible. 
Artificial crisis can only occur with a free 
pleurB.l cavity B.nd may be expected in 50~'~ of cases 
trested before the fourth day. I1his statement is 
predictable and is in accord with clinical experience. 
Nothing is B.ccomplished by compression tree.tment un-
less B.rtificial crisis is achieved. (34) 
Specific se~lm therapy is applicable to About 
50% of allpa.tients with lobar pneumonia.. Artifici!'ll 
pneumothorax is capable of producing an artificia.l 
crisis in about the same proportion of cases and can 
be used in any B.nd all types of lobar pneumonia if 
the involvement is unilsteral. Both specific serum 
end pneumothorax must be used early to be effective. 
Artificial pneumothorax, properly used is e. real and 
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